Glycosylated Hemoglobin and the Risk of Retinopathy in Insulin-Dependent Diabetes Mellitus

  • Warram J
  • Manson J
  • Krolewski A
65Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

To the Editor: Since we found evidence of a threshold for the effect of hyperglycemia on the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus (IDDM),1 we used published data to examine whether there was a similar pattern for diabetic retinopathy. In the Diabetes Control and Complications Trial (DCCT),2 the incidence of the development or progression of retinopathy in the group assigned to intensive treatment fluctuated around 2.0 per 100 person-years in the nine deciles of the hemoglobin A1c distribution below 8.5 percent and rose to 7.0 per 100 person-years in the highest decile, consistent with a threshold. © 1995, Massachusetts Medical Society. All rights reserved.

Cite

CITATION STYLE

APA

Warram, J. H., Manson, J. E., & Krolewski, A. S. (1995). Glycosylated Hemoglobin and the Risk of Retinopathy in Insulin-Dependent Diabetes Mellitus. New England Journal of Medicine, 332(19), 1305–1306. https://doi.org/10.1056/nejm199505113321915

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free